Search Results

Keywords: sativex

First medical cannabis sales in Colombia imminent – a year later than expected

Colombia’s delayed medical cannabis industry could see its first sale within days, according to one of the country’s leading producers. Khiron Life Sciences announced Friday that it became “the first company” authorized to sell medical cannabis in Colombia. The Latin American nation’s medical cannabis industry had been expected to launch in 2019, so the announcement […]

Read More

German government doesn’t know how much cannabis sold in 2019, can’t estimate 2020 demand

The German federal government admitted that it doesn’t know how much medical cannabis was sold in the country in 2019. The government also cannot estimate demand for 2020. Lack of accurate official information can make it harder for businesses trying to plan their strategies in Europe’s most important medical marijuana market. It also can lead […]

Read More

Australia expedites review of medical cannabis product Epidiolex

The only medical cannabis product in the Australian Register of Therapeutic Goods might soon be joined by another. Australian health regulators quietly gave Epidiolex, a cannabidiol medication, orphan designation and priority review status in late 2019. The designations allow the Therapeutic Goods Administration to waive application and evaluation fees, as well as expedite its assessment […]

Read More

GW Pharma beats projections with $108M in Q4 sales thanks to CBD drug

A popular cannabis-derived epilepsy treatment is increasing sales for a London company making pharmaceutical treatments from marijuana. London-based GW Pharmaceuticals told investors Monday that it rang up $108 million in sales last quarter and $309 million for calendar 2019. The company’s fourth-quarter sales beat consensus analyst expectations of $102.4 million. GW attributed the sales figures to physicians […]

Read More

The Big Year

Cannabis companies are wagering hundreds of millions of dollars on Colombia’s emerging cannabis industry, betting the Latin American country will become a major production and export hub. But 2019 wasn’t the year in which these businesses began churning out medical cannabis products. This year will be key for Colombian operators to show investors that the […]

Read More

Top 10 global cannabis stories of 2019: WHO backs rescheduling, Linton out at Canopy, Canadian firms eye US & more

Cannabis markets in Canada and elsewhere in the world went on a roller-coaster ride in 2019, as irrational expectations gave way to more realistic market assessments. Global medical marijuana markets, corporations and top executives experienced breakthroughs and setbacks this past year. That’s the gist of the 10 most widely read business stories carried by Marijuana Business Daily […]

Read More

Analysis: Germany’s medical cannabis market loses momentum but on pace to surpass 100 million euros

Insurance reimbursements for medical cannabis in Germany reached a new high during the July-September period, according to recently published data by the German National Association of Statutory Health Insurance Funds (GKV-Spitzenverband). However, the data also suggests that growth in medical marijuana sales is losing momentum as double-digit gains in MMJ reimbursements become harder to maintain. Statutory health insurance reimbursements […]

Read More

Brazil’s new medical cannabis rules reject domestic cultivation, potentially setting up large import market

Brazilian health authorities rejected domestic cultivation of medical marijuana but agreed to permit the distribution of medicinal cannabis products that have not completed clinical trials, potentially setting up one of the largest import markets in the world. The new rules, adopted Tuesday, allow bulk imports and sales in pharmacies for the first time. Tuesday’s decision – involving […]

Read More

England’s health insurance has covered only 18 ‘unlicensed’ cannabis prescriptions

Since a new law took effect a year ago, England’s National Health Service (NHS) has reimbursed patients on only 18 occasions for “unlicensed” cannabis-based products that have not undergone clinical trials, according to government data. In the case of private prescriptions – which are paid out of pocket by patients – the number of prescriptions reached 104. The data […]

Read More

Week in Review: Cannabis layoffs, regulators scrutinizing vitamin E acetate as vape villain, MI adult-use launch looms & more

Layoff announcements continue to weigh on the marijuana industry, state regulators focus on vitamin E acetate additive in vaporizer products as the vape crisis continues, Michigan businesses set their game plans for a December adult-use MJ launch, and more of the week’s top cannabis news. Pink slips pile up  Three well-known California cannabis companies this […]

Read More